INS and chronic kidney disease: Consistent with the entire cohort, after excluding patients on oral antidiabetic or insulin therapy, patients with CKD (but not those without CKD) exhibited a reduction in FPG levels by 6.7 mg/dl (P = .043) at 6 months post-RDN.